ARI Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
ARI Therapeutics General Information
Description
Developer of pharmaceutical products designed to address respiratory diseases through innovative drug research and development. The company is currently operating in Stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- Austin, TX
- United States
Corporate Office
- Austin, TX
- United States
ARI Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | Completed | Stealth | ||||
| 1. Seed Round | 01-Apr-2026 | Completed | Stealth |
ARI Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Santé Ventures | Venture Capital | Minority | ||
| MAxL | Accelerator/Incubator |
ARI Therapeutics FAQs
-
Where is ARI Therapeutics headquartered?
ARI Therapeutics is headquartered in Austin, TX.
-
What industry is ARI Therapeutics in?
ARI Therapeutics’s primary industry is Drug Discovery.
-
Is ARI Therapeutics a private or public company?
ARI Therapeutics is a Private company.
-
What is ARI Therapeutics’s current revenue?
The current revenue for ARI Therapeutics is .
-
Who are ARI Therapeutics’s investors?
Santé Ventures and MAxL have invested in ARI Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process